02 July 2021
The third day of the 6th World Psoriasis and Psoriatic Arthritis Conference (WPPAC) 2021 features plenary sessions on hot topics like comorbidities, prevention, and long-term use of biologics. There are also two more keynote lectures, oral abstracts, and a new theme-of-the-day for the Complementary Program.
Plenary and interactive Q&A sessions
The first plenary session of Day 3 is on the topic of comorbidities, an issue of special relevance to multidisciplinary care and patient priorities. This session includes updates from Professor Lone Skov, Dr. Alexis Ogdie-Beatty, and Dr. Josefin Lysell. The speakers stick around for a live Q&A after their talks.
This plenary session is all about prevention. The different aspects of this complex topic are addressed by Professor Wayne Gulliver, Dr. Frank Behrens, and Dr. Alexander Egeberg, who also participate in an interactive Q&A at the end of the plenary.
The final plenary session on Day 3 features the very hot topic of 20 years of biologics. First, Professor Carle Paul speaks about “looking back and looking ahead” – long-term safety, risk management and future potential. Then Professors Kilian Eyerich and Laura Coates talk about treatment strategies and unmet needs of treating psoriasis/psoriatic arthritis. Finally, Dr Alexander Egeberg and Professor Dafna Gladman discuss the potential for the prevention of comorbidities. Attendees have the opportunity to weigh in during a live Q&A at the end.
Professor Nehal Mehta from the US speaks and answers questions about vascular inflammation in chronic inflammatory disease.
Professor Mats Lekander from Sweden speaks and answers questions on the hot topic of the pathogenesis of depression in inflammation (chronic and acute).
The Complementary Program is primarily directed at allied health professionals, non-specialists, patient leaders, and industry representatives. It is broken up into two sessions on Day 3, each with its own theme: first, access to care and management; then, focus on unmet needs
Session 5 of the Complementary Program features lectures on rapid access and early intervention. First, Lars Werner from the Danish Psoriasis Association presents a white paper on climate treatment in the Nordic region. Then, Professor Jörg Prinz talks about inflammatory disease and a new way of thinking. Finally, IFPA’s Elisa Martini presents the Psoriatic Disease Response Index. The session ends with a live Q&A.
Session 6 of the Complementary Program focuses on taking global knowledge and implementation at the national level. First, advocate and expert Silvia Fernandez Barrio gives an introduction titled “More than skin deep”. Then, Professor April Armstrong continues on the theme with a talk about global psoriatic disease beyond survey. Next, Conference Secretary Barbra Bohannan uses learnings from Sweden to frame her lecture on improving treatment and care in primary care settings. Then, Professor Cristina Echeverría discusses national guideline implementation using the Latest therapeutic guidelines for the management of psoriasis in Argentina as an example. Lastly, Dr. Roop Saini talks about putting psoriasis into focus at a national level and unmet needs in Africa using learnings from Kenya. Speakers are also available for a live Q&A.
Oral abstract presentations
Day 3 features findings from two major abstracts:
Identification of serum protein biomarkers at baseline to distinguish radiographic progressors from non-progressors in patients with active Psoriatic Arthritis (PsA) presented by Orla Coleman
Immune checkpoint inhibitors in patients with preexisting psoriasis associated with manageable disease exacerbations and excellent tumor outcomes presented by Briana Halle
Poster abstracts are available online from Wednesday, June 30. Don’t forget to stop by the virtual abstract hall to learn about the very latest research on psoriasis and psoriatic arthritis.
Join us tomorrow for Day 4!
Theme: “Connected, informed, and united to improve multidisciplinary care for people with psoriasis & psoriatic arthritis”
Dates: June 30 – July 3, 2021
Venue: Virtual Conference broadcast from Stockholm, Sweden
Target group: Dermatologists, rheumatologists and general practitioners and allied health professionals with an interest in psoriasis and psoriatic arthritis
Twitter: @PsoriasisIFPA, #WPPAC21
Camille Lancelot, IFPA Communications Manager.
Telephone: +46 73 961 15 65